Search Results 111-120 of 16833 for Fibronolytic

  1. A Study Comparing Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients with Non-valve Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention - Mayo Clinic

    A Study Comparing Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients with Non-valve Atrial Fibrillation ...

  2. A Study of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction - Mayo Clinic

    Patients transferred in to an UPSTREAM hospital are eligible for inclusion, but the timing for OAP agent administration and diagnostic catheterization begin ...

  3. A Study to Evaluate the Effectiveness and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema in Adolescents and Adults - Mayo Clinic

    ... fibrinolytics within 2 weeks prior to entering the observation period as ... Short-term prophylaxis is defined as C1-INH, attenuated androgens, or anti- ...

  4. Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) - Mayo Clinic

    Concomitant treatment with other antithrombotic agents (ASA >100 mg/day, fibrinolytic therapy, or chronic (>4 days/week) use of nonsteroidal antiinflammatory ...

  5. Metformin revisited - Mayo Clinic

    ... fibrinolysis." Metformin's most common side effect is gastrointestinal distress, which includes nausea, diarrhea and upper abdominal discomfort. Dr. Nair ...

  6. Publications - Zech G. Franks, M.D. - Mayo Clinic

    Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis. Arterioscler Thromb Vasc Biol. 2017 Oct; 37 (10):1819 ...

  7. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    Blood Coagul Fibrinolysis. 2021 Oct 1; 32 (7):528-530. View PubMed; Fei F, Boshell N, Williams LA 3rd. Predictability and efficacy of therapeutic plasma ...

  8. Ram Kadirvel, Ph.D. - Mayo Clinic Faculty Profiles

    ... fibrinolysis. Dr. Kadirvel's research strives to uncover the mechanisms responsible for thrombolysis resistance, including the role of hypoxia and post ...

  9. Dose of Labeled Cholesterol for Kinetics: A Pilot Study - Mayo Clinic

    About this study. This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.

  10. Publications - Tahir Mehmood, M.D. - Mayo Clinic

    Drugs that affect blood coagulation, fibrinolysis and hemostasis Side Effects of Drugs Annual. 2015; 37:419-32. Mehmood T, Auerbach M, Earley CJ, Allen RP ...